Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Germline testing in patients with early-onset pancreatic cancer (EOPC).
Authors
Hamid Ehsan
Atrium Health Levine Cancer Institute, Charlotte, NC
James Thomas Symanowski , Arunkumar Krishnan , Aly Athens , Katherine Wilson , Katie Tobik , Sara Elrefai , Mohamed E. Salem , Jimmy J. Hwang , Darryl Chang , Kunal C. Kadakia , Hamid Ehsan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 639)
DOI
10.1200/JCO.2024.42.3_suppl.639
Abstract #
639
Poster Bd #
K8
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Real world rates of genetic referrals and germline testing in patients with prostate adenocarcinoma at an academic cancer center in southern New Jersey.
First Author: Christopher Ambrogi
Poster
2022 ASCO Quality Care Symposium
Single-center comparison of cancer genetics referral rates for patients with pancreatic cancer following implementation of a best practice advisory: A quality improvement project.
First Author: Stephanie Rivera Morales
Poster
2022 ASCO Annual Meeting
Germline predisposition in oncologic and dermatologic melanoma cohorts.
First Author: Pauline Funchain
Poster
2020 Gastrointestinal Cancers Symposium
Changing the landscape of germline testing in patients with pancreatic adenocarcinoma.
First Author: Aly Athens